Advice for cardiology healthcare professionals: management of abnormal uterine bleeding in women with heart disease
Women's Health Plan team: womenshealthplan@gov.scot.
Warning
Women's Health Plan team to coordinate ongoing development through links with Menstrual Health Clinical Network and Cardiology Task Force groups.
Email: womenshealthplan@gov.scot.
The content of toolkit has been reviewed by members of the menstrual health clinical network and cardiology task force and approved by authors (Dr Jackie Maybin, Professor Anna Glasier, Dr Marianne Watters). Approval date January 2026.
UKMEC table reproduced with permission from COSRH on the basis that it is a non-commercial product that will be freely available to access, and on the basis that CoSRH is acknowledged as the author.
Where external sources are cited, they have been linked to within the toolkit.
All icons are sourced from Flaticon.com [https://www.flaticon.com/ 
], accessed through the licence held by Tactuum Ltd as software provider of the RDS platform.
Risks have been mitigated by providing links to guidelines support information in this toolkit.
No new medicines are being approved and the suggested example treatments come from pre-existing guidelines.
The content and structure of the toolkit was created with input from three clinicians (Dr Marianne Watters, Dr Jackie Maybin, Professor Anna Glasier) and was then reviewed by healthcare professionals from the Scottish Government Menstrual Health Clinical Network and Cardiologists from the Scottish Government Cardiology networks.
Authors:
- Dr Marianne Watters, Clinical Research Fellow.
- Dr Jackie Maybin, Reader and Consultant Gynaecologist.
- Professor Anna Glasier, Women's Health Champion for Scotland.
Guideline drafts reviewed by members of the Scottish Government Menstrual Health Clinical Network and Dr Ross McGeoch (CMO Speciality Advisor for Cariology) and Dr Lorna Swan (Clinical Lead for Scottish Adult Congenital Service).
Author of UKMEC tables: College of Sexual and Reproductive Healthcare (CoSRH).
Feedback and/or complaints can be sent to: womenshealthplan@gov.scot.
User testing was conducted in December 2025 to assure usability, navigation, readability and appropriate formatting. The feedback provided was positive and the suggested changes have been made to the toolkit.
An accessibility check of the toolkit was done in January 2026 using the RDS standard operating procedure. The accessibility of the RDS platform technology is confirmed in the RDS accessibility statement at the bottom of every website page.
This toolkit should be used by qualified health and social care staff and should not be used by members of the public as a substitute for professional advice.
NHS Board users should confirm with their Area Drug and Therapeutics Committee (ADTC) that the prescribing guidance in this toolkit is in line with local policy.